Logo image of CROS.PA

CROSSWOOD (CROS.PA) Stock Fundamental Analysis

EPA:CROS - Euronext Paris - Matif - FR0000050395 - Common Stock - Currency: EUR

10.8  0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CROS. CROS was compared to 69 industry peers in the Real Estate Management & Development industry. While CROS has a great health rating, its profitability is only average at the moment. CROS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CROS had positive earnings in the past year.
CROS had a positive operating cash flow in the past year.
CROS had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CROS reported negative operating cash flow in multiple years.
CROS.PA Yearly Net Income VS EBIT VS OCF VS FCFCROS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

CROS's Return On Assets of 1.47% is fine compared to the rest of the industry. CROS outperforms 63.77% of its industry peers.
With a Return On Equity value of 1.86%, CROS perfoms like the industry average, outperforming 59.42% of the companies in the same industry.
The Return On Invested Capital of CROS (0.59%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CROS is below the industry average of 4.48%.
The 3 year average ROIC (0.44%) for CROS is below the current ROIC(0.59%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.47%
ROE 1.86%
ROIC 0.59%
ROA(3y)3.96%
ROA(5y)5.5%
ROE(3y)5.07%
ROE(5y)7.37%
ROIC(3y)0.44%
ROIC(5y)0.63%
CROS.PA Yearly ROA, ROE, ROICCROS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 -2 4 6 8 10

1.3 Margins

CROS has a Profit Margin of 150.55%. This is amongst the best in the industry. CROS outperforms 97.10% of its industry peers.
CROS's Operating Margin of 86.10% is amongst the best of the industry. CROS outperforms 97.10% of its industry peers.
CROS's Operating Margin has declined in the last couple of years.
CROS has a better Gross Margin (81.23%) than 79.71% of its industry peers.
In the last couple of years the Gross Margin of CROS has grown nicely.
Industry RankSector Rank
OM 86.1%
PM (TTM) 150.55%
GM 81.23%
OM growth 3Y-0.97%
OM growth 5Y-16.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y3.08%
CROS.PA Yearly Profit, Operating, Gross MarginsCROS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 400 600

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CROS is destroying value.
Compared to 1 year ago, CROS has about the same amount of shares outstanding.
Compared to 5 years ago, CROS has about the same amount of shares outstanding.
CROS has a better debt/assets ratio than last year.
CROS.PA Yearly Shares OutstandingCROS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
CROS.PA Yearly Total Debt VS Total AssetsCROS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 4.21 indicates that CROS is not in any danger for bankruptcy at the moment.
CROS has a better Altman-Z score (4.21) than 94.20% of its industry peers.
CROS has a debt to FCF ratio of 2.27. This is a good value and a sign of high solvency as CROS would need 2.27 years to pay back of all of its debts.
CROS has a Debt to FCF ratio of 2.27. This is amongst the best in the industry. CROS outperforms 94.20% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that CROS is not too dependend on debt financing.
CROS's Debt to Equity ratio of 0.04 is amongst the best of the industry. CROS outperforms 82.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.27
Altman-Z 4.21
ROIC/WACC0.08
WACC7.67%
CROS.PA Yearly LT Debt VS Equity VS FCFCROS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

CROS has a Current Ratio of 1.28. This is a normal value and indicates that CROS is financially healthy and should not expect problems in meeting its short term obligations.
CROS has a Current ratio of 1.28. This is comparable to the rest of the industry: CROS outperforms 55.07% of its industry peers.
CROS has a Quick Ratio of 1.28. This is a normal value and indicates that CROS is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.28, CROS is doing good in the industry, outperforming 71.01% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.28
CROS.PA Yearly Current Assets VS Current LiabilitesCROS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

CROS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 226.76%, which is quite impressive.
Looking at the last year, CROS shows a decrease in Revenue. The Revenue has decreased by -6.15% in the last year.
CROS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.96% yearly.
EPS 1Y (TTM)226.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%289.84%
Revenue 1Y (TTM)-6.15%
Revenue growth 3Y-12.91%
Revenue growth 5Y-2.96%
Sales Q2Q%0.54%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CROS.PA Yearly Revenue VS EstimatesCROS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 77.14, which means the current valuation is very expensive for CROS.
The rest of the industry has a similar Price/Earnings ratio as CROS.
The average S&P500 Price/Earnings ratio is at 25.91. CROS is valued rather expensively when compared to this.
Industry RankSector Rank
PE 77.14
Fwd PE N/A
CROS.PA Price Earnings VS Forward Price EarningsCROS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CROS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 61.99
EV/EBITDA N/A
CROS.PA Per share dataCROS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

CROS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.91%, CROS is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 7.55, CROS has a dividend in line with its industry peers.
With a Dividend Yield of 0.91, CROS pays less dividend than the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 0.91%

5.2 History

The dividend of CROS is nicely growing with an annual growth rate of 125.18%!
Dividend Growth(5Y)125.18%
Div Incr Years1
Div Non Decr Years1
CROS.PA Yearly Dividends per shareCROS.PA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0.1 0.2 0.3

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
CROS.PA Yearly Income VS Free CF VS DividendCROS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M 8M

More info and screens

CROSSWOOD

EPA:CROS (5/22/2025, 7:00:00 PM)

10.8

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners95.04%
Ins Owner ChangeN/A
Market Cap114.80M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.91%
Yearly Dividend0.11
Dividend Growth(5Y)125.18%
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 77.14
Fwd PE N/A
P/S 114.01
P/FCF 61.99
P/OCF 44.67
P/B 1.41
P/tB 1.41
EV/EBITDA N/A
EPS(TTM)0.14
EY1.3%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.17
FCFY1.61%
OCF(TTM)0.24
OCFY2.24%
SpS0.09
BVpS7.66
TBVpS7.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.47%
ROE 1.86%
ROCE 0.86%
ROIC 0.59%
ROICexc 0.6%
ROICexgc 0.6%
OM 86.1%
PM (TTM) 150.55%
GM 81.23%
FCFM 183.91%
ROA(3y)3.96%
ROA(5y)5.5%
ROE(3y)5.07%
ROE(5y)7.37%
ROIC(3y)0.44%
ROIC(5y)0.63%
ROICexc(3y)0.45%
ROICexc(5y)0.65%
ROICexgc(3y)0.45%
ROICexgc(5y)0.65%
ROCE(3y)0.65%
ROCE(5y)0.93%
ROICexcg growth 3Y-15.8%
ROICexcg growth 5Y-23.21%
ROICexc growth 3Y-15.79%
ROICexc growth 5Y-23.21%
OM growth 3Y-0.97%
OM growth 5Y-16.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y3.08%
F-Score7
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.27
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 13.55
Cash Conversion N/A
Profit Quality 122.16%
Current Ratio 1.28
Quick Ratio 1.28
Altman-Z 4.21
F-Score7
WACC7.67%
ROIC/WACC0.08
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)41.17%
Cap/Sales(5y)29.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)226.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%289.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.15%
Revenue growth 3Y-12.91%
Revenue growth 5Y-2.96%
Sales Q2Q%0.54%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y144.23%
EBIT growth 3Y-13.76%
EBIT growth 5Y-18.9%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y240.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y549.3%
OCF growth 3Y-22.79%
OCF growth 5Y-21.99%